Science China Life SciencesGenomicsPeer-reviewed journal article
Discovery and Engineering of a New BvCas12a Nuclease for Mammalian Genome Editing and Nucleic Acid Detection
Xuechun SHENiD, Lei HuangiD, Dan WangiD, Qi CheniD, Baitao LiiD, Chuan LiuiD, Ke CheniD, Yuanqiang ZouiD, Liang XiaoiD, Yuan JiangiD, Hongxia LaniD, Yue ZhengiD
Abstract
Cas12a is an RNA-guided endonuclease that has emerged as a powerful gene-editing tool. We have identified a novel Cas protein, BvCas12a, from Butyricimonas virosa with a 5-TYTN protospacer adjacent motif (PAM). BvCas12a exhibits double-stranded DNA cleavage activity in vitro and genome editing activity in eukaryotic cells. Though the editing efficiency of BvCas12a is marginally lower than that of AsCas12a, the editing specificity of BvCas12a in eukaryotic cells is comparable or superior to that of AsCas12a. Moreover, BvCas12a exhibits substantial collateral activity and can detect HPV DNA effectively and accurately in conjunction with isothermal amplification, highlighting its potential in nucleic acid diagnostics. Furthermore, we have engineered BvCas12a to create two variants, BvCas12a-R (N549R, T606P) and BvCas12a-RVR (N549R, K555V, C559R, T606P). These variants recognize expanded 5-YYN and 5-YN PAM in vitro, respectively. Additionally, they exhibit higher editing activity than wild-type BvCas12a and recognize 5-YYN PAM in vivo at all sites detected. In conclusion, we have identified a novel BvCas12a protein with high specificity and engineered two variants with broader PAM compatibility and improved genome editing efficiency. These findings offer a potent gene editing tool for application in scientific research, gene therapy, and nucleic acid diagnostics.
- assay: DNA methylation
- assay: whole-genome sequencing
- research focus: variant calling
- research focus: protein design
- research focus: drug response / drug discovery
- research focus: gene regulatory network inference
- approach: experimental assay
- Citations
- 1
- FWCI
- 2.09
- Field percentile
- top 21%
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Systematic dissection of Cas12a-mediated precision genome editing defines design principles for genome-scale variant engineering
Antoine Delhaye, Vlad S Băţăgui, … Sibylle Chantal Vonesch·bioRxiv·Jun 29, 2026
- An engineered xCas12i with high activity, high specificity and broad PAM range
- Directed evolution expands CRISPR-Cas12a genome editing capacity
Enbo Ma, Kai Chen, … Jennifer A. Doudna·Nucleic Acids ResearchPeer-reviewed·Jul 8, 2025
- Pervasive off-target and double-stranded DNA nicking by CRISPR-Cas12a
K. Murugan, A. Seetharam, … D. G. Sashital·bioRxiv·Jun 2, 2019
- Improved Genome Editing by an Engineered CRISPR-Cas12a
E. Ma, K. Chen, … J. A. Doudna·bioRxiv·Sep 2, 2022
- Optimization of NLS Composition Improves CRISPR-Cas12a Editing Rates in Human Primary Cells
Kevin Luk, Pengpeng Liu, … Scot A. Wolfe·bioRxiv·Feb 1, 2022